Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

There is no known standard case report form (CRF) available for this instrument. CDISC created this CRF to represent the instrument, which CDISC believes is in the public domain. This is not an endorsement of the instrument. The The creation of this instrument was based on based on published articles describing the instrument as well as input from PASI instrument subject matter experts.  Sponsors Sponsors may create this instrument’s CRF using their style guidelines, but they need to maintain the wording and order of the questions/items and responses as described on the CRF.

...

The CDISC Intellectual Property Policy can be found on the CDISC website at: https://www.cdisc.org/about/bylaws.

Info
titleReviewers input requested

CDISC would appreciate supplement reviewers' input on their experience in using the PASI FEDLMAN instrument regarding what responses are being used for symptoms "erythema/redness", "thickness/induration" and "desquamation/scaling". There are 3 possible references that were found to explain PASI:

  • Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii65–ii68.
    • Responses for symptoms are: none, slight, mild, moderate, severe.
  • Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. doi: 10.1159/000250839. PMID: 357213.
    • Responses for symptoms are: none, slight, moderate, striking, exceptionally striking.
  • EMA guideline on Clinical Investigation of Medicinal Products Indicated for the Treatment of Psoriasis (https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-indicated-treatment-psoriasis_en.pdf)
    • Responses for symptoms are based on Fredriksson (no symptoms, slight, moderate, marked, very marked) and are grouped as: mild to moderate, moderate, moderate to severe, and severe. 

CDISC would appreciate reviewer help regarding which list of responses are used (those that mirror Feldman, Fredriksson, EMA, or some other combination).

If the responses list is not in a majority (per public comment), it will be considered “undetermined.” The supplement will allow a sponsor’s list of responses, as was done in the CDISC PGI and CGI supplements.

1.1 Representations and Warranties, Limitations of Liability, and Disclaimers

1.1 Representations and Warranties, Limitations of Liability, and Disclaimers

This document is a supplement to the SDTMIG for Human Clinical This document is a supplement to the SDTMIG for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material.

...

CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the PASI V2FREDRIKSSON in the CDISC library of QRS data standards supplements. Hence, CDISC developed RSTESTCD and RSTEST for each item based on the actual text on the instrument. There may be many versions of this instrument. CDISC has chosen to use this version as the data standard.

...

Note: CDISC Controlled Terminology is maintained by National Cancer Institute (NCI) Enterprise Vocabulary Services (EVS). The most recent version should be accessed through the CDISC website at: https://www.cdisc.org/standards/terminology/controlled-terminology.

Reference for the PASI V2FREDRIKSSON:

Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii65–ii68Fredriksson T, Pettersson U. Severe Psoriasis - Oral Therapy with a New Retinoid. Dermatologica. 1978; 157(4):238-244.


3 The RS Domain Model

3.1 Assumptions for the RS Domain Model

All assumptions and business rules described in the SDTMIG RS domain are applicable to this supplement. Additional assumptions specific to the PASI V2 are FREDRIKSSON are listed below.

The PASI V2 is a tool used to assess the severity of psoriasis. The PASI V2 PASI FREDRIKSSON is a tool used to assess the severity of psoriasis. However, there is no standard set of responses for the PASI that is used throughout industry. This supplement uses the Fredriksson article as the stand for responses with some slight modifications from SME input. The PASI FREDRIKSSON divides the body into 4 sections (i.e.,  headhead, trunk, upper extremities, lower extremities) and assesses symptom severity and the percentage of each area affected by psoriasis. The symptoms are rated on a 5-point scale and the area is rated on a 7-point scale. Subscores for each section of the body and a total score are also captured.

  1. The scale points for the symptoms include a numeric rating (0-4) and a definition of what is represented by the rating (e.g., 0 = "None")= "None"). Instead of "striking" and "exceptionally striking" that are referenced in the Fredriksson article, "severe" and "very severe" were used due to SME input suggesting these responses are used more frequently. For the PASI V2FREDRIKSSON, RSORRES is populated with the text description; the numeric rating is represented in the standardized character and numeric result variables RSSTRESC and RSSTRESN.

    1. CDISC created a CRF based on the Feldman article using the symptom terms "erythema/redness", "thickness/induration", and "desquamation/scaling". Per subject-matter expert recommendations, desquamation was included with scaling even though desquamation is not referenced in the Feldman Fredriksson article.
  2. The scale points for the area include a numeric rating (0-6) and a definition of what is represented by the rating (e.g., 0 = "0 (clear)No involvement"). For the area, RSORRES is populated with the text description; the numeric rating is represented in the standardized character and numeric result variables RSSTRESC and RSSTRESN.
  3. The PASI V2 instrument FREDRIKSSON instrument includes subscores and a total score that are considered as captured data on the CRF and are not considered as derived in the example below. These scores may be submitted in SDTM or derived in the Analysis Data Model (ADaM) per scoring instructions from the Feldman Fredriksson reference.

    1. If operationally defined by the sponsor, it is the sponsor's responsibility to set the --DRVFL flag based on their eCRF process to derive subtotals and total scores. An investigator-derived score will be considered a captured score and not flagged. When subtotal and total scores are derived by the sponsor, the derived flag (--DRVFL) is set to "Y". However, when the subtotal and total scores are received from a central provider or vendor, the value would go into --ORRES and --DRVFL would be null (see SDTMIG Section 4.1.8.1, Origin Metadata for Variables).

    2. If scores are received by the sponsor, it is recommended that they are submitted to SDTM and verified in ADaM.

  4. Records are created in rs.xpt for every item on the instrument

    1. For items with no data, RSORRES, RSSTRESC, and RSSTRESN are all missing and RSSTAT = "NOT DONE".  If the reason is known, that reason is represented in RSREASND (e.g., RSREASND = "REFUSED"). If the reason is unknown, RSSTAT = "NOT DONE" and RSREASND is missing.

  5. Terminology

    1. RSCAT, RSTESTCD, and RSTEST values are included in CDISC Controlled Terminology.

    2. A full list of value sets for the result field is provided in Section 4, SDTM Mapping Strategy.

3.2 Example for the PASI

...

FREDRIKSSON RS Domain Model

The PASI V2 FREDRIKSSON example below shows the terminology used to implement the instrument in the RS domain. This example shows the data for 1 subject collected at the baseline visit for the PASI V2 instrument. The the terminology used to implement the instrument in the RS domain. The example uses CDISC Controlled Terminology for RSTESTCD, RSTEST, and RSCAT. All original results, matching the CRF item response text, are represented in RSORRES. This result is then represented as a standard numeric score in RSSTRESN and as a standard character representation in RSSTRESC.

...


The table represents the items from the PASI V2 instrumentFREDRIKSSON instrument.

Dataset wrap
Namers
Rowcaps
Rows 1-16:Show the symptom and area responses for the baseline visit.
Rows 17-29:Show the subscores and total scores for the baseline visit.
Rows 30-59:Show the subject was not evaluated on this instrument at visit 2. Since the reason for not completing the visit was collected, the date is included in RSDTC for when the visit was planned.
Dataset2
RowSTUDYIDDOMAINUSUBJIDRSSEQRSTESTCDRSTESTRSCATRSORRESRSSTRESCRSSTRESNRSSTATRSREASNDRSLOBXFLVISITNUMRSDTC
1STUDYXRS2324-P00011PASI0201PASI0301PASI02PASI03-Head: Erythema/Redness
PASI V2FREDRIKSSONSlight11

Y12015-05-15
2STUDYXRS2324-P00012PASI0202PASI0302PASI02PASI03-Head: Thickness/Induration
PASI V2FREDRIKSSONNone00

Y12015-05-15
3STUDYXRS2324-P00013PASI0203PASI0303PASI02PASI03-Head: Desquamation/Scaling
PASI V2FREDRIKSSONNone00

Y12015-05-15
4STUDYXRS2324-P00014PASI0204PASI0304PASI02PASI03-Head: Area Score
PASI V2FREDRIKSSON<10%11

Y12015-05-15
5STUDYXRS2324-P00015PASI0205PASI0305PASI02PASI03-Up Extrem: Erythema/Redness
PASI V2FREDRIKSSONMildModerate22

Y12015-05-15
6STUDYXRS2324-P00016PASI0206PASI0306PASI02PASI03-Up Extrem: Thickness/Induration
PASI V2FREDRIKSSONSlight11

Y12015-05-15
7STUDYXRS2324-P00017PASI0207PASI0307PASI02PASI03-Up Extrem: Desquamation/Scaling
PASI V2FREDRIKSSONMildModerate22

Y12015-05-15
8STUDYXRS2324-P00018PASI0208PASI0308PASI02PASI03-Up Extrem: Area Score
PASI V2FREDRIKSSON30 - <50%33

Y12015-05-15
9STUDYXRS2324-P00019PASI0209PASI0309PASI02PASI03-Trunk: Erythema/Redness
PASI V2FREDRIKSSONNone00

Y12015-05-15
10STUDYXRS2324-P000110PASI0210PASI0310PASI02PASI03-Trunk: Thickness/Induration
PASI V2FREDRIKSSONNone00

Y12015-05-15
11STUDYXRS2324-P000111PASI0211PASI0311PASI02PASI03-Trunk: Desquamation/Scaling
PASI V2FREDRIKSSONNone00

Y12015-05-15
12STUDYXRS2324-P000112PASI0212PASI0312PASI02PASI03-Trunk: Area Score
PASI V2FREDRIKSSONNo involvement0 (clear)00

Y12015-05-15
13STUDYXRS2324-P000113PASI0213PASI0313PASI02PASI03-Low Extrem: Erythema/Redness
PASI V2FREDRIKSSONSlight11

Y12015-05-15
14STUDYXRS2324-P000114PASI0214PASI0314PASI02PASI03-Low Extrem: Thickness/Induration
PASI V2FREDRIKSSONSlight11

Y12015-05-15
15STUDYXRS2324-P000115PASI0215PASI0315PASI02PASI03-Low Extrem: Desquamation/Scaling
PASI V2FREDRIKSSONSlight11

Y12015-05-15
16STUDYXRS2324-P000116PASI0216PASI0316PASI02PASI03-Low Extrem: Area Score
PASI V2FREDRIKSSON10 - <30%22

Y12015-05-15
17STUDYXRS2324-P000117PASI0217PASI0317PASI02PASI03-Head: Sum of Symptom Scores
PASI V2FREDRIKSSON111

Y12015-05-15
18STUDYXRS2324-P000118PASI0218PASI0318PASI02PASI03-Head: Sum X Area
PASI V2FREDRIKSSON111

Y12015-05-15
19STUDYXRS2324-P000119PASI0219PASI0319PASI02PASI03-Head: Sum X Area X 0.1
PASI V2FREDRIKSSON0.10.10.1

Y12015-05-15
20STUDYXRS2324-P000120PASI0220PASI0320PASI02PASI03-Up Extrem: Sum of Symptom Scores
PASI V2FREDRIKSSON555

Y12015-05-15
21STUDYXRS2324-P000121PASI0221PASI0321PASI02PASI03-Up Extrem: Sum X Area
PASI V2FREDRIKSSON151515

Y12015-05-15
22STUDYXRS2324-P000122PASI0222PASI0322PASI02PASI03-Up Extrem: Sum X Area X 0.2
PASI V2FREDRIKSSON333

Y12015-05-15
23STUDYXRS2324-P000123PASI0223PASI0323PASI02PASI03-Trunk: Sum of Symptom Scores
PASI V2FREDRIKSSON000

Y12015-05-15
24STUDYXRS2324-P000124PASI0224PASI0324PASI02PASI03-Trunk: Sum X Area
PASI V2FREDRIKSSON000

Y12015-05-15
25STUDYXRS2324-P000125PASI0225PASI0325PASI02PASI03-Trunk: Sum X Area X 0.3
PASI V2FREDRIKSSON000

Y12015-05-15
26STUDYXRS2324-P000126PASI0226PASI0326PASI02PASI03-Low Extrem: Sum of Symptom Scores
PASI V2FREDRIKSSON333

Y12015-05-15
27STUDYXRS2324-P000127PASI0227PASI0327PASI02PASI03-Low Extrem: Sum X Area
PASI V2FREDRIKSSON666

Y12015-05-15
28STUDYXRS2324-P000128PASI0228PASI0328PASI02PASI03-Low Extrem: Sum X Area X 0.4
PASI V2FREDRIKSSON2.42.42.4

Y12015-05-15
29STUDYXRS2324-P000129PASI0229PASI0329PASI02PASI03-Total Sum
PASI V2FREDRIKSSON5.55.55.5

Y12015-05-15
30STUDYXRS2324-P000130PASI0201PASI0301PASI02PASI03-Head: Erythema/Redness
PASI V2FREDRIKSSON


NOT DONEREFUSED
22015-06-14
31STUDYXRS2324-P000131PASI0202PASI0302PASI02PASI03-Head: Thickness/Induration
PASI V2FREDRIKSSON


NOT DONEREFUSED
22015-06-14
32STUDYXRS2324-P000132PASI0203PASI0303PASI02PASI03-Head: Desquamation/Scaling
PASI V2FREDRIKSSON


NOT DONEREFUSED
22015-06-14
...














59STUDYXRS2324-P000159PASI0229PASI0329PASI02PASI03-Total Sum
PASI V2FREDRIKSSON


NOT DONEREFUSED
22015-06-14

...

This section is used for reference regarding the CRF data capture and to understand the alignment of the instrument to the SDTM RS domain. It also provides guidance on how the result variables (RSORRES, RSSTRESC, and RSSTRESN) should be populated.


RSTESTCD = "PASI0201PASI0301" RSTEST = "PASI02PASI03-Head: Erythema/Redness"

RSTESTCD = "PASI0202PASI0302" RSTEST = "PASI02PASI03-Head: Thickness/Induration"

RSTESTCD = "PASI0203PASI0303" RSTEST = "PASI02PASI03-Head: Desquamation/Scaling"

RSTESTCD = "PASI0205PASI0305" RSTEST = "PASI02PASI03-Up Extrem: Erythema/Redness"

RSTESTCD = "PASI0206PASI0306" RSTEST = "PASI02PASI03-Up Extrem: Thickness/Induration"

RSTESTCD = "PASI0207PASI0307" RSTEST = "PASI02PASI03-Up Extrem: Desquamation/Scaling"

RSTESTCD = "PASI0209PASI0309" RSTEST = "PASI02PASI03-Trunk: Erythema/Redness"

RSTESTCD = "PASI0210PASI0310" RSTEST = "PASI02PASI03-Trunk: Thickness/Induration"

RSTESTCD = "PASI0211PASI0311" RSTEST = "PASI02PASI03-Trunk: Desquamation/Scaling"

RSTESTCD = "PASI0213PASI0313" RSTEST = "PASI02PASI03-Low Extrem: Erythema/Redness"

RSTESTCD = "PASI0214PASI0314" RSTEST = "PASI02PASI03-Low Extrem: Thickness/Induration"

RSTESTCD = "PASI0215PASI0315" RSTEST = "PASI02PASI03-Low Extrem: Desquamation/Scaling"

...

RSORRESRSSTRESCRSSTRESN
None00
Slight11
MildModerate22
ModerateSevere33Severe
Very severe44


RSTESTCD = "PASI0204PASI0304" RSTEST = "PASI02PASI03-Head: Area Score"

RSTESTCD = "PASI0208PASI0308" RSTEST = "PASI02PASI03-Up Extrem: Area Score"

RSTESTCD = "PASI0212PASI0312" RSTEST = "PASI02PASI03-Trunk: Area Score"

RSTESTCD = "PASI0216PASI0316" RSTEST = "PASI02PASI03-Low Extrem: Area Score"

RSORRESRSSTRESCRSSTRESN
0 (clear)No involvement00
<10%11
10% - <30%22
30% - <50%33
50% - <70%44
70% - <90%55
90% - 100%66

...